Casey Feeney, PA
Physician Assistant · Buffalo, NYNPI 1861994683
Payments from drug & device makers
Across 300 payments — averaging $21.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$804
- AbbVie$779
- Insulet Corporation$461
- Lilly USA, LLC$430
- Novo Nordisk$371
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,489100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 49 | $1,115 |
| AstraZeneca | 33 | $804 |
| AbbVie | 35 | $779 |
| Insulet Corporation | 18 | $461 |
| Lilly USA, LLC | 24 | $430 |
| Novo Nordisk | 23 | $371 |
| Pfizer | 16 | $274 |
| Biohaven Pharmaceuticals, Inc. | 2 | $232 |
| Bayer | 11 | $189 |
| Gilead | 7 | $184 |
| Amgen | 3 | $161 |
| Boehringer Ingelheim | 9 | $150 |
| Dexcom, Inc. | 10 | $143 |
| E.r. Squibb & Sons, L.L.C. | 8 | $140 |
| Abbott | 5 | $138 |
| Mylan Specialty L.p. | 7 | $135 |
| Phathom Pharmaceuticals, Inc. | 4 | $102 |
| Exact Sciences | 5 | $102 |
| Viiv Healthcare Company | 4 | $71 |
| Johnson & Johnson | 4 | $67 |
| Scilex Pharmaceuticals Inc. | 3 | $56 |
| Grifols USA, LLC | 3 | $51 |
| Advanced Oxygen Therapy Inc. | 2 | $45 |
| Indivior Inc. | 2 | $41 |
| Novartis | 2 | $40 |
| Almatica Pharma LLC | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Aurinia Pharma U.S., Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Merck | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$248
- NURTEC ODT$232
- BREZTRI$227
- Repatha$125
- AREXVY$125
- FreeStyle Libre Pro$115
- Omnipod$105
- FARXIGA$102
- VRAYLAR$100
How this compares
$6,489 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 192 | $147,232 |
| OzempicSemaglutide | 60 | $78,695 |
| TrulicityDulaglutide | 51 | $66,506 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 18 | $66,458 |
| JardianceEmpagliflozin | 41 | $64,030 |
| RybelsusSemaglutide | 27 | $49,217 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $46,583 |
| LinzessLinaclotide | 35 | $43,936 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 40 | $31,609 |
| MounjaroTirzepatide | 24 | $29,950 |
| EliquisApixaban | 33 | $28,977 |
| FarxigaDapagliflozin Propanediol | 27 | $25,198 |
| JanuviaSitagliptin Phosphate | 19 | $24,054 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 31 | $16,464 |
| Omnipod Classic Pods (Gen 3)Insulin Pump Cart,cont Inf,rf | 20 | $11,283 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $1,115 | $163,696223 claims |
| Novo NordiskOzempic, Rybelsus | $371 | $127,91287 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro | $430 | $102,267115 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $804 | $80,38393 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $150 | $70,47853 claims |
| GileadBiktarvy | $184 | $66,45818 claims |
| AbbVieLinzess | $779 | $43,93635 claims |
| PfizerEliquis | $274 | $28,97733 claims |
| MerckJanuvia | $22 | $24,05419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Buffalo
- Scott SpringerBuffalo$95K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.